CDKN1B and intrahepatic cholangiocarcinoma: Reduced cyclin D1 (CCND1) and increased cyclin-dependent kinase inhibitor 2B (CDKN1B, also known as p27Kip1) downregulate the proliferation and self-renewal of ICC-SC by interfering with entry into the cell cycle [17].